Cart
sales@molnova.com
P300/CBP-IN-3
CAS No. 2299226-01-8
P300/CBP-IN-3( —— )
Catalog No. M22063 CAS No. 2299226-01-8
P300/CBP-IN-3 is an inhibitor of p300/CBP histone acetyltransferase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 215 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 312 | In Stock |
|
| 25MG | 561 | In Stock |
|
| 50MG | 793 | In Stock |
|
| 100MG | 1097 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2186 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameP300/CBP-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionP300/CBP-IN-3 is an inhibitor of p300/CBP histone acetyltransferase.
-
DescriptionP300/CBP-IN-3 is an inhibitor of p300/CBP histone acetyltransferase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorhistone acetyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2299226-01-8
-
Formula Weight431.53
-
Molecular FormulaC24H29N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL (579.33 mM; Need ultrasonic)
-
SMILESCCN(CC)C1=CC=C(C=N1)C1=NC2=CC(=CC=C2N1CC1=NN(CC)C=C1)C(=O)NC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Medina, et al. 5-(1H-Benzo[d]imidazol-2-yl)pyridin-2-amine and 5-(3H-imidazo[4,5-b]pyridin-6-yl)pyridin-2-amine derivatives as c-MYC and p300/CBP histone acetyltransferase inhibitors for treating cancer and their preparation.
molnova catalog
related products
-
PF-05231023
PF-05231023 is a long-acting fibroblast growth factor 21 (FGF21) analog and is an FGF21-receptor agonist. It is also suitable for development as a potential treatment for T2DM. PF-05231023 is a analog of long-acting fibroblast growth factor 21.
-
Neuropeptide SF (hum...
Neuropeptide SF human augments paraventricular corticotrophin-releasing hormone (CRH) release and increases adrenocorticotropic hormone (ACTH) and corticosterone levels in the plasma. Neuropeptide SF human play a physiologic role in the regulation of such circadian functions as the activity of motor centers and the HPA axis, through the release of CRH.
-
MPO-IN-28
MPO-IN-28 is a novel potent irreversible Myeloperoxidase (MPO) inhibitor with IC50 of 44 nM.
